Relapsed or Refractory AML and Other Hematologic Malignancies
1 clinical trials · Condition
◉ Watch Relapsed or Refractory AML and Other Hematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies. (NCT06812104) | Kyowa Kirin Co., Ltd. | 2024-10-10 |
Track Relapsed or Refractory AML and Other Hematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.